Regulation of Ets function by protein–protein interactions
The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
Abstract
Ets proteins are a family of transcription factors that share an 85 amino acid conserved DNA binding domain, the ETS domain. Over 25 mammalian Ets family members control important biological processes, including cellular proliferation, differentiation, lymphocyte development and activation, transformation and apoptosis by recognizing the GGA core motif in the promoter or enhancer of their target genes. Protein - protein interactions regulates DNA binding, subcellular localization, target gene selection and transcriptional activity of Ets proteins. Combinatorial control is a characteristic property of Ets family members, involving interaction between Ets and other key transcriptional factors such as AP-1, NFkappaB and Pax family members. Specific domains of Ets proteins interact with many protein motifs such as bHLH, bZipper and Paired domain. Such interactions coordinate cellular processes in response to diverse signals including cytokines, growth factors, antigen and cellular stresses.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ultimately, the protein–protein interface may provide a unique target for intervention, thus, providing a novel approach for blocking aberrant signalling pathways or reversing the malignant phenotype associated with oncogenic transcription factors [123].”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [123]
In the citing paper
“ETS proteins display a variety of such cooperative partnerships, as previously reviewed (1, 2, 151, 152).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [151]
Citations
Cites
Regulation of matrix metalloproteinase expression in tumor invasion
Westermarck, J., & Kähäri, V. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.8.781 · Cited by 1,494 · cited 1×
“Adjacent Ets and AP-1 binding sites occur in a large number of promoter/enhancer elements (Wasylyk et al., 1993; Westermarck and Kahari, 1999) and functional cooperation between Ets and AP-1 is critical for controlled expression of many genes, including cytokines (Gottschalk et al., 1993; Wang et…”
BackgroundGolub, T. R., Barker, G. F., Lovett, M., & Gilliland, D. G. (1994) · Cell · doi:10.1016/0092-8674(94)90322-0 · Cited by 1,155
Retinoblastoma protein represses transcription by recruiting a histone deacetylase
Magnaghi-Jaulin, L., Groisman, R., Naguibneva, I., Robin, P., Lorain, S., Le Villain, J. P., Troalen, F., Trouche, D., & Harel-Bellan, A. (1998) · Nature · doi:10.1038/35410 · Cited by 909
The Ets family of transcription factors
WASYLYK, B., HAHN, S. L., & GIOVANE, A. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb19864.x · Cited by 842 · cited 1×
“Adjacent Ets and AP-1 binding sites occur in a large number of promoter/enhancer elements (Wasylyk et al., 1993; Westermarck and Kahari, 1999) and functional cooperation between Ets and AP-1 is critical for controlled expression of many genes, including cytokines (Gottschalk et al., 1993; Wang et…”
BackgroundA TEL-JAK2 Fusion Protein with Constitutive Kinase Activity in Human Leukemia
Lacronique, V., Boureux, A., Della Valle, V., Poirel, H., Quang, C. T., Mauchauffé, M., Berthou, C., Lessard, M., Berger, R., Ghysdael, J., et al. (1997) · Science · doi:10.1126/science.278.5341.1309 · Cited by 791 · cited 1×
“…lead to a permanent signal activity in signaling transduction, which are characteristic of the leukemic cells (Ghysdael and Boureux, 1997; Golub et al., 1994; 1996; Ho et al., 1999; Jousset et al., 1997; Lacronique et al., 1997; Papadopoulos et al., 1995; Peeters et al., 1997; Romana et al., 1995).”
BackgroundCrystal structure of the heterodimeric bZIP transcription factor c-Fos–c-Jun bound to DNA
Glover, J. N. M., & Harrison, S. C. (1995) · Nature · doi:10.1038/373257a0 · Cited by 735 · cited 1×
“…not p65 (Bassuk et al., 1997) Ets/bZIP factors Crystal structures of basic leucine zipper (bZIP) factors demonstrate that the basic region of bZIP factors mediates protein ±DNA interaction, while the leucine zipper domain contributes to protein ± protein interactions (Glover and Harrison, 1995).”
BackgroundTernary complex factors: growth factor regulated transcriptional activators
Treisman, R. (1994) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(94)90097-3 · Cited by 676 · cited 1×
“The regulation of TCFs activity is an important mechanism by which the serum response element responds to growth factor signals (Treisman, 1994).”
BackgroundGiese, K., Kingsley, C., Kirshner, J. R., & Grosschedl, R. (1995) · Genes & Development · doi:10.1101/gad.9.8.995 · Cited by 541 · cited 1×
“…1998 Pongubala et al., 1992 TFE3 Ets1/PU.1 Ig m A Tian et al., 1999 enhancer Dang et al., 1998 PEBP2aB Ets1 TcRa A Wooton et al., 1994 /AML1/ Giese et al., 1995 CBFa2 Mo-MLV A Sheridan et al., 1995 HIV-1 Sun et al., 1995 Kim et al., 1999 AML1 MEF IL3 A Mao et al., 1999 AML1/ETO Promoter R…”
BackgroundThe t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion
Romana, S., Mauchauffe, M., Le Coniat, M., Chumakov, I., Le Paslier, D., Berger, R., & Bernard, O. (1995) · Blood · doi:10.1182/blood.v85.12.3662.bloodjournal85123662 · Cited by 530 · cited 1×
“…lead to a permanent signal activity in signaling transduction, which are characteristic of the leukemic cells (Ghysdael and Boureux, 1997; Golub et al., 1994; 1996; Ho et al., 1999; Jousset et al., 1997; Lacronique et al., 1997; Papadopoulos et al., 1995; Peeters et al., 1997; Romana et al., 1995).”
BackgroundStructure and function of helix-loop-helix proteins
Murre, C., Bain, G., van Dijk, M. A., Engel, I., Furnari, B. A., Massari, M. E., Matthews, J. R., Quong, M. W., Rivera, R. R., & Stuiver, M. H. (1994) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(94)90001-9 · Cited by 511 · cited 1×
“…The basic helix ± loop ± helix (bHLH) transcription factors form homo- or heterodimers through their bHLH domains, enabling the basic regions to form a bipartite DNA-binding motif that recognize `E-box', and play a crucial role in controlling of speci®c developmental processes (Murre et al., 1994).”
Background
Research works printed but not linked: 7
- Bhat NK and Papas TS. . 1994 Challenges of Modern Medicine, Vol. 5: Ares-Serono Symposia 5. Verna R and Shamoo A. (eds) pp 63–68.
- Boise LH, Petryniak B, Mao X, June CH, Wang CY, Lindsten T, Bravo R, Kovary K, Leiden JM and Thompson CB. . 1993 Mol. Cell Biol. 13: 1911–1919. · doi:10.1128/mcb.13.3.1911-1919.1993 · Paper page
- Graves B and Peterson J (eds). . Advances in cancer research, Vol 75. Academic Press: San Diego, California 1998 pp1–55.
- Pongubala JM, Nagulapalli S, Klemsz MI, McKercher SR, Maki RA and Atchison ML. . 1992 Mol. Cell. Biol. 12: 368–378. · doi:10.1128/mcb.12.1.368-378.1992 · Paper page
- Shore P and Sharrocks AD. . 1994 Mol. Cell Biol. 14: 3283–3291. · doi:10.1128/mcb.14.5.3283-3291.1994 · Paper page
- Watson DK, Li R, Sementchenko VI, Mavrothalassitis G and Seth A. . 2001 Encylopedia of Cancer. Bertino JR (ed.). Academic Press in press.
- Wotton D, Ghysdael J, Wang S, Speck NA and Owen MJ. . 1994 Mol. Cell Biol. 14: 840–850. · doi:10.1128/mcb.14.1.840-850.1994 · Paper page
Cited by
The ETS-domain transcription factor family
Sharrocks, A. D. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35099076 · Cited by 1,086
Molecular biology of the Ets family of transcription factors
Oikawa, T., & Yamada, T. (2003) · Gene · doi:10.1016/s0378-1119(02)01156-3 · Cited by 688
On schemes of combinatorial transcription logic
Buchler, N. E., Gerland, U., & Hwa, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0930314100 · Cited by 680
Genomic and biochemical insights into the specificity of ETS transcription factors
Hollenhorst, P. C., McIntosh, L. P., & Graves, B. J. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.79.081507.103945 · Cited by 490
“ETS proteins display a variety of such cooperative partnerships, as previously reviewed (1, 2, 151, 152).”
Barolo, S., & Posakony, J. W. (2002) · Genes & Development · doi:10.1101/gad.976502 · Cited by 468
“…(e.g., Schule et al. 1988; Bailey and Posakony 1995; Giese et al. 1995; Rothenberg and Ward 1996; Pearce et al. 1998; Hepker et al. 1999; Certel et al. 2000; Flores et al. 2000; Halfon et al. 2000; Li et al. 2000; Ramana et al. 2000; Xu et al. 2000; Affolter et al. 2001; Knirr and Frasch 2001).”
BackgroundETS transcription factors and their emerging roles in human cancer
Seth, A., & Watson, D. K. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.013 · Cited by 469
“Many transcription factors have their DNA binding sites adjacent to EBS (for reviews, see [8,9]).”
BackgroundSelf-citationBiology of EWS/ETS fusions in Ewing's family tumors
Arvand, A., & Denny, C. T. (2001) · Oncogene · doi:10.1038/sj.onc.1204598 · Cited by 348
“Protein-protein interactions have a dominant impact on ETS function (for review see Li et al., 2000).”
BackgroundHollenhorst, P. C., Shah, A. A., Hopkins, C., & Graves, B. J. (2007) · Genes & Development · doi:10.1101/gad.1561707 · Cited by 290
“For example, ETS1 could function with as many as nine different transcription factors (Li et al. 2000).”
BackgroundSpatially resolved transcriptomics reveals the architecture of the tumor-microenvironment interface
Hunter, M. V., Moncada, R., Weiss, J. M., Yanai, I., & White, R. M. (2021) · Nature Communications · doi:10.1038/s41467-021-26614-z · Cited by 285
DeepSTARR predicts enhancer activity from DNA sequence and enables the de novo design of enhancers
de Almeida, B. P., Reiter, F., Pagani, M., & Stark, A. (2021) · doi:10.1101/2021.10.05.463203 · Cited by 284
Ets proteins in biological control and cancer
Hsu, T., Trojanowska, M., & Watson, D. K. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20012 · Cited by 287
“Combinatorial interactions of Ets factors with other proteins, including other sequence specific transcription factors, result in context-dependent transcriptional regulation and define target gene specificity (reviewed in [Li et al., 2000a]).”
BackgroundSelf-citationde Almeida, B. P., Reiter, F., Pagani, M., & Stark, A. (2022) · Nature Genetics · doi:10.1038/s41588-022-01048-5 · Cited by 283
“For example, ETS and AP-1 TFs always interacted according to mode 1 and 3, respectively, and mode 1 of the ETS TFs suggests direct protein–protein interactions with other TFs, which has indeed been observed 80,81 .”
BackgroundYang, L., Xia, L., Wu, D. Y., Wang, H., Chansky, H. A., Schubach, W. H., Hickstein, D. D., & Zhang, Y. (2002) · Oncogene · doi:10.1038/sj.onc.1204998 · Cited by 273
“ETS proteins usually bind to DNA as monomers via the ETS domain, however it has been shown that the DNA binding activity is enhanced or modulated through interactions with other transcription factors (Li et al., 2000).”
BackgroundHollenhorst, P. C. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh906 · Cited by 214
“The apparent affinity is determined by intrinsic affinity for the sequence of the binding site as well as interactions with other proteins, with both processes subject to regulation by post-translational modifications (1,2,10,11).”
Mathas, S., Janz, M., Hummel, F., Hummel, M., Wollert-Wulf, B., Lusatis, S., Anagnostopoulos, I., Lietz, A., Sigvardsson, M., Jundt, F., et al. (2006) · Nature Immunology · doi:10.1038/ni1285 · Cited by 183
Oncogenic Partnerships: EWS-FLI1 Protein Interactions Initiate Key Pathways of Ewing's Sarcoma
Erkizan, H. V., Uversky, V. N., & Toretsky, J. A. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2261 · Cited by 160
Nehyba, J., Hrdlickova, R., & Bose, H. R. (2009) · Molecular Biology and Evolution · doi:10.1093/molbev/msp167 · Cited by 150
“…IRF4-SG proteins are present in sponges including 1) a short variable N-terminus that precedes the IRF DBD; 2) an approximately 150 amino acid long, proline- and serine/ threonine-rich middle region separating the DBD from IAD1; and 3) an approximately 50 amino acid long, variable C-terminus.”
BackgroundMolecular mechanisms of ETS transcription factor-mediated tumorigenesis
Kar, A., & Gutierrez‐Hartmann, A. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.838202 · Cited by 167
“While there is a fair bit of complexity in the number of ETS-interacting proteins identified to date, SRF, AP-1 and NF-kB appear to be key factors in the ETS cancer interactome (Li et al., 2000).”
BackgroundInfluentialEts2 Maintains hTERT Gene Expression and Breast Cancer Cell Proliferation by Interacting with c-Myc
Xu, D., Dwyer, J., Li, H., Duan, W., & Liu, J.-P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800790200 · Cited by 142
Oncogene-mediated alterations in chromatin conformation
Rickman, D. S., Soong, T. D., Moss, B., Mosquera, J. M., Dlabal, J., Terry, S., MacDonald, T. Y., Tripodi, J., Bunting, K., Najfeld, V., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112570109 · Cited by 134
“ERG interacts with several cofactors (14) and other transcription factors including AR to regulate the expression of thousands of genes that favor dedifferentiation, cell invasion, and neoplastic transformation of prostate epithelium when overexpressed (15–20).”
BackgroundWhen Ets transcription factors meet their partners
Verger, A., & Duterque‐Coquillaud, M. (2002) · BioEssays · doi:10.1002/bies.10068 · Cited by 134
Galang, C. K., Muller, W. J., Foos, G., Oshima, R. G., & Hauser, C. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311887200 · Cited by 132
Foxs and Ets in the transcriptional regulation of endothelial cell differentiation and angiogenesis.
Dejana, E., Taddei, A., & Randi, A. (2007) · Biochimica et Biophysica Acta · doi:10.1016/j.bbcan.2007.05.003 · Cited by 146
Rizzo, F. M., Fernandez-Serra, M., Squarzoni, P., Archimandritis, A., & Arnone, M. I. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2006.08.012 · Cited by 125
Oncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancer
Bilke, S., Schwentner, R., Yang, F., Kauer, M. O., Jug, G., Walker, R. L., Davis, S. R., Zhu, Y. J., Pineda, M. A., Meltzer, P. S., et al. (2013) · Genome Research · doi:10.1101/gr.151340.112 · Cited by 122
Wang, J. Q., Tang, Q., Parelkar, N. K., Liu, Z., Samdani, S., Choe, E. S., Yang, L., & Mao, L. (2004) · Molecular Neurobiology · doi:10.1385/mn:29:1:01 · Cited by 113
Identification of 9 Genes Differentially Expressed in Head and Neck Squamous Cell Carcinoma
Gonzalez, H. E., Gujrati, M., Frederick, M. J., Henderson, Y. C., Jayakumar, A., Spring, P. M., Mitsudo, K., Kim, H.-W., & Clayman, G. L. (2003) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.129.7.754 · Cited by 112
“The specific functions of EHF are as of yet unknown; however, other ETS transcription factors have been involved in cellular proliferation, differentiation, and apoptosis.(25) Moreover, TGM3, which has also been shown to be downregulated in esophageal cancer,(26) is involved in stabilizing the cell cornified envelope.”
BackgroundUnderstanding the Role of ETS-Mediated Gene Regulation in Complex Biological Processes
Findlay, V. J., LaRue, A. C., Turner, D. P., Watson, P. M., & Watson, D. K. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-407190-2.00001-0 · Cited by 125
Self-citationTiteux, M., Pendaries, V., Tonasso‐Calvière, L., Décha, A., Bodemer, C., & Hovnanian, A. (2007) · Human Mutation · doi:10.1002/humu.20647 · Cited by 112
“…at the Ets/AP-1 site enhances the synthesis of MMP1 and TIMP1 [Logan et al., 1996; Tower et al., 2003], and that the nature of the Ets and AP1 factors within this complex could act negatively or positively on the level of transcription of their target genes [Buttice et al., 1996; Li et al., 2000].”
BackgroundZhu, S., Barshow, S., Wildonger, J., Jan, L. Y., & Jan, Y. N. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118595109 · Cited by 133
“However, Ets family proteins with transcriptional activation activity, such as Pnt homolog Ets1, could also function as transcriptional repressors in a cell type- and promoter-dependent manner (30).”
BackgroundDadi, S., Noir, S. L., Payet‐Bornet, D., Lhermitte, L., Cabeza, J. Z., Bergeron, J., Villarèse, P., Vachez, E., Dik, W. A., Millien, C., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.013 · Cited by 96
Lindemann, R. K., Ballschmieter, P., Nordheim, A., & Dittmer, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105816200 · Cited by 108
Regulation of endothelial cell development by ETS transcription factors
Meadows, S. M., Myers, C. T., & Krieg, P. A. (2011) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.09.009 · Cited by 107
Genome-wide Analysis of CDX2 Binding in Intestinal Epithelial Cells (Caco-2)
Boyd, M., Hansen, M., Jensen, T. G. K., Perearnau, A., Olsen, A. K., Bram, L. L., Bak, M., Tommerup, N., Olsen, J., & Troelsen, J. T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.089516 · Cited by 100
Molecular mechanisms of megakaryopoiesis
Szalai, G., LaRue, A. C., & Watson, D. K. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6190-8 · Cited by 125
Self-citationEts-dependent Regulation of Target Gene Expression during Megakaryopoiesis
Jackers, P., Szalai, G., Moussa, O., & Watson, D. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407489200 · Cited by 91
Self-citationThe induction of CCN2 by TGFβ1 involves Ets-1
van Beek, J. P., Kennedy, L., Rockel, J. S., Bernier, S. M., & Leask, A. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1890 · Cited by 82
“To extend these results, we found that the ETS family member Fli-1 could activate the CCN2 promoter in fibroblasts in a fashion dependent on the GGAA motif (Figure 1c).”
BackgroundInfluentialets‐1 is transcriptionally up‐regulated by H 2 O 2 via an antioxidant response element
Wilson, A., Gemin, A., Espiritu, R., & Singh, G. (2005) · The FASEB Journal · doi:10.1096/fj.05-4401fje · Cited by 86
“Several studies have described post transcriptional regulation of Ets-1 activity, such as the effect of phosphorylation mediated by the MAPK pathway on transactivation potential, as well as the importance of interactions with other transcription factors determining specificity of targets (20, 21).”
BackgroundId proteins in epithelial cells
Coppé, J., Smith, A. P., & Desprez, P. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00014-4 · Cited by 78
Selective Regulation of Vitamin D Receptor-Responsive Genes by TFIIH
Drané, P., Compe, E., Catez, P., Chymkowitch, P., & Egly, J.-M. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.10.007 · Cited by 75
Gupta, P., Gurudutta, G. U., Saluja, D., & Tripathi, R. P. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00757.x · Cited by 74
“Ultimately, the protein–protein interface may provide a unique target for intervention, thus, providing a novel approach for blocking aberrant signalling pathways or reversing the malignant phenotype associated with oncogenic transcription factors [123].”
BackgroundIs PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis?
Dakic, A., Wu, L., & Nutt, S. L. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.01.006 · Cited by 72
Sp100 Interacts with ETS-1 and Stimulates Its Transcriptional Activity
Wasylyk, C., Schlumberger, S. E., Criqui-Filipe, P., & Wasylyk, B. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2687-2702.2002 · Cited by 78
EAPII interacts with ETS1 and modulates its transcriptional function
Pei, H., Yordy, J. S., Leng, Q., Zhao, Q., Watson, D. K., & Li, R. (2003) · Oncogene · doi:10.1038/sj.onc.1206374 · Cited by 70
“Previous work utilizing this screen demonstrated that ETS1 interacts with the Daxx protein, referred to as ETS1associated protein I (EAPI) (Li et al., 2000b).”
BackgroundMethodSelf-citationEts-1 Positively Regulates Fas Ligand Transcription via Cooperative Interactions with Sp1
Kavurma, M. M., Bobryshev, Y. V., & Khachigian, L. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200463200 · Cited by 68
RetractedInterplay among transcription factors Ets21c, Fos and Ftz-F1 drives JNK-mediated tumor malignancy
Külshammer, E., Mundorf, J., Kilinc, M., Frommolt, P., Wagle, P., & Uhlirova, M. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.020719 · Cited by 65
“…and ETS-AP-1 DNA elements in the regulatory regions of numerous human cancer-related genes, such as genes for cytokines, MMPs (e.g. stromelysin, collagenase) and MMP inhibitors (e.g. TIMP) (Miner et al., 1991;Kerppola et al., 1993; Li et al., 2000; Chinenov and Kerppola, 2001; Biddie et al., 2011).”
Petrovic, N., Bhagwat, S. V., Ratzan, W. J., Ostrowski, M. C., & Shapiro, L. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308071200 · Cited by 66
Rogers, M. A., Winter, H., Beckmann, I., Schweizer, J., Langbein, L., & Praetzel, S. (2004) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2003.22128.x · Cited by 64
DNA Binding Domain-independent Pathways Are Involved in EWS/FLI1-mediated Oncogenesis
Welford, S. M., Hebert, S. P., Deneen, B., Arvand, A., & Denny, C. T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106757200 · Cited by 65
Meadows, S. M., Salanga, M. C., & Krieg, P. A. (2009) · Development · doi:10.1242/dev.029538 · Cited by 66
“These binding partners act to modulate ETS DNA-binding affinity and transcriptional activity (Li et al., 2000).”
BackgroundFontanet, P., Irala, D., Alsina, F. C., Paratcha, G., & Ledda, F. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0928-13.2013 · Cited by 62
“…transcription of multiple genes through protein–protein interactions with other cellular partners present at defined times and cellular conditions, as well as through specific protein modifications, such as phosphorylation and acetylation (Li et al., 2000; Verger and Duterque-Coquillaud, 2002).”
BackgroundShi, J., Qu, Y., Li, X., Sui, F., Yao, D., Yang, Q., Shi, B., Ji, M., & Hou, P. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.346 · Cited by 61
“It is the fact that the DNA binding domains of ETS factors are very similar, thus their specific roles in tumorigenesis are largely dependent on other factors including interaction with other nuclear factors such as transcription factors, co-activators or co-repressor.(43,44) Moreover, the activities of ETS proteins a…”
BackgroundHutton, J. J., Jegga, A. G., Kong, S., Gupta, A., Ebert, C. L., Williams, S. S., Katz, J. D., & Aronow, B. J. (2004) · BMC Genomics · doi:10.1186/1471-2164-5-82 · Cited by 62
“1/Ets, Ikaros, E2A, EBF, PAX5, GATA3, NFAT, cMYB, and OCT-2 [1-4].”
Makowski, M. M., Willems, E., Fang, J., Choi, J., Zhang, T., Jansen, P. W. T. C., Brown, K. M., & Vermeulen, M. (2016) · PROTEOMICS · doi:10.1002/pmic.201500327 · Cited by 58
“Although most ETS-transcription factors are reported to bind monomerically, cooperative, antagonistic, and combinatorial effects are common [33].”
BackgroundO'Reilly, D., Quinn, C. M., El-Shanawany, T., Gordon, S., & Greaves, D. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212150200 · Cited by 57
Homotypic and heterotypic interactions of EWS, FLI1 and their oncogenic fusion protein
Spahn, L., Siligan, C., Bachmaier, R., Schmid, J. A., Aryee, D. N. T., & Kovar, H. (2003) · Oncogene · doi:10.1038/sj.onc.1206810 · Cited by 56
“This domain contains the ets-DNA-binding domain of FLI1 and a putative Cterminal transactivation domain (Bertolotti et al., 1998; Ohno et al., 1993) but not the pointed domain, which is known to be involved in protein–protein interactions between different ets proteins (Li et al., 2000).”
BackgroundSP100 expression modulates ETS1 transcriptional activity and inhibits cell invasion
Yordy, J. S., Li, R., Sementchenko, V. I., Pei, H., Muise‐Helmericks, R. C., & Watson, D. K. (2004) · Oncogene · doi:10.1038/sj.onc.1207891 · Cited by 55
“Two of these, EAP1 (ETS1-associated Protein1), subsequently identified as Daxx (Yang et al., 1997; Li et al., 2000b), and EAPII (Pei et al., 2003) have been previously described.”
BackgroundMethodResultSelf-citationAberrant expression of ETS1 and ETS2 proteins in cancer
Fry, E. A., & Inoue, K. (2018) · Cancer Reports and Reviews · doi:10.15761/crr.1000151 · Cited by 56
“ETS1 and ETS2 are representative members of the ETS family of transcription factors and are downstream effectors of the RAS/RAF/ERK pathway [14-19] (Figure 2).”
BackgroundActivated Ets2 Is Required for Persistent Inflammatory Responses in the Motheaten Viable Model
Guo, W., Guo, J., Doseff, A. I., Kusewitt, D. F., Man, A. K., Oshima, R. G., & Ostrowski, M. C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.1374 · Cited by 51
“Genes such as Bcl-X and TNFidentified as Ets2 targets are also targets for other transcription factors known to play important role in inflammatory responses, AP1 and NF- B (21, 22, 26).”
BackgroundSynergistic action of E74B and ecdysteroid receptor in activating a 20-hydroxyecdysone effector gene
Sun, G., Zhu, J., Chen, L., & Raikhel, A. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503501102 · Cited by 51
Ets-1 Protects Vascular Smooth Muscle Cells from Undergoing Apoptosis by Activating p21WAF1/Cip1
Zhang, C., Kavurma, M. M., Lai, A. K. W., & Khachigian, L. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304328200 · Cited by 51
Wittwer, J., Marti-Jaun, J., & Hersberger, M. (2005) · Human Mutation · doi:10.1002/humu.20273 · Cited by 52
“Several proteins have been identified as modulators of SPI1 [Li et al., 2000], including the retinoblastoma protein [Hagemeier et al., 1993], the basal transcription factor TBP [Hagemeier et al., 1993], the transcriptional coactivators CBP/p300 [Yamamoto et al., 1999], the transcription factors…”
BackgroundVerger, A., Buisine, E., Carrère, S., Wintjens, R., Flourens, A., Coll, J., Stéhelin, D., & Duterque-Coquillaud, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010208200 · Cited by 50
Fontanet, P., Ríos, A. S., Alsina, F. C., Paratcha, G., & Ledda, F. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw372 · Cited by 56
“These transcription factors regulate gene expression of different genes through protein – protein interactions and through speci fi c posttranslational modi fi cations such as phosphorylation, acetylation, and sumoylation (Li et al. 2000; Verger and Duterque-Coquillaud 2002; Bojovic and Hassell 2008).”
BackgroundKim, E. L., Gunther, W. C., Yoshizato, K., Meissner, H., Zapf, S., Nüsing, R. M., Yamamoto, H., Meir, E. G. V., Deppert, W., & Giese, A. (2003) · Oncogene · doi:10.1038/sj.onc.1207155 · Cited by 51
“Since the intrinsic DNA binding of ets-1 is weak (Li et al., 2000) and can be enhanced in vitro by ets-1-specific antibodies (Reisdorff et al., 2002), we also examined DNA binding in the presence of the ets-1-specific antibody C-20.”
BackgroundXu, L., Hu, H., Zheng, L.-S., Wang, M.-Y., Mei, Y., Peng, L.-X., Qiang, Y.-Y., Li, C., Meng, D., Wang, M., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.04.002 · Cited by 53
MicroRNA-124 inhibits cellular proliferation and invasion by targeting Ets-1 in breast cancer
Li, W., Zang, W., Liu, P., Wang, Y., Du, Y., Chen, X., Deng, M., Sun, W., Wang, L., Zhao, G., et al. (2014) · Tumor Biology · doi:10.1007/s13277-014-2402-2 · Cited by 48
The Transcription Factor Elf3 Is Essential for a Successful Mesenchymal to Epithelial Transition
Şengez, B., Aygün, I., Shehwana, H., Toyran, N., Avcı, S. T., Konu, Ö., Stemmler, M. P., & Alotaibi, H. (2019) · Cells · doi:10.3390/cells8080858 · Cited by 53
Paratore, C., Giambonini-Brugnoli, G., Lee, H.-Y., Suter, U., & Sommer, L. (2002) · Developmental Biology · doi:10.1006/dbio.2002.0795 · Cited by 51
Tacke, F., Liedtke, C., Bocklage, S., Manns, M. P., & Trautwein, C. (2005) · Gut · doi:10.1136/gut.2005.065086 · Cited by 52
Abe, H., Okazawa, M., & Nakanishi, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109940108 · Cited by 46
“The ETS transcription factors also interact with transcriptional partners to enhance transcriptional activation synergistically (25).”
BackgroundCaspase-1 Is a Direct Target Gene of ETS1 and Plays a Role in ETS1-Induced Apoptosis
Pei, H., Li, C., Adereth, Y., Hsu, T., Watson, D. K., & Li, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3566 · Cited by 46
“The status of these and other interacting partners might be critical for the role of ETS1 in apoptosis induction (5, 38).”
BackgroundSelf-citationmiR-377 functions as a tumor suppressor in human clear cell renal cell carcinoma by targeting ETS1
Wang, R., Ma, Y., Yu, D., Zhao, J., & Ma, P. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.01.012 · Cited by 47
ELF5 isoform expression is tissue-specific and significantly altered in cancer
Piggin, C., Roden, D. L., Gallego‐Ortega, D., Lee, H. J., Oakes, S. R., & Ormandy, C. J. (2016) · Breast Cancer Research · doi:10.1186/s13058-015-0666-0 · Cited by 50
“In many proteins, SAM and/or PNT domains act as protein–protein interaction modules, an important mechanism of biological specificity for ETS factors, which often bind only weakly to DNA in the absence of binding partners or posttranslational modifications [3, 12].”
BackgroundPrognostic values of ETS-1, MMP-2 and MMP-9 expression and co-expression in breast cancer patients
Puzović, V., Brčić, I., Ranogajec, I., & Jakić-Razumović, J. (2014) · Neoplasma · doi:10.4149/neo_2014_054 · Cited by 44
“Altered expression of ETS-1 transcription factor is often found in tumors [5-9].”
BackgroundConstitutive and Cytokine-Induced Expression of the ETS Transcription Factor ESE-3 in the Lung
Silverman, E. S., Baron, R. M., Palmer, L. J., Le, L., Hallock, A., Subramaniam, V., Riese, R. J., McKenna, M. D., Gu, X., Libermann, T. A., et al. (2002) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2002-0011oc · Cited by 43
Abedin, M., Nguyen, A., Jiang, N., Perry, C. E., Shelton, J. M., Watson, D. K., & Ferdous, A. (2014) · Circulation Research · doi:10.1161/circresaha.1134303145 · Cited by 20
“Indeed, cooperative actions among numerous ETS factors, including Etv2, Fli1, and Erg, and other transcription factors are known to play essential roles in endothelial gene expression during development.(10,31) Consistent with these studies, a cooperative action between Fli1 and Erg is required for hematopoiesis in mi…”
BackgroundSelf-citationThe Fli-1 Transcription Factor Regulates the Expression of CCL5/RANTES
Richard, M. L., Sato, S., Suzuki, E., Williams, S. V., Nowling, T. K., & Zhang, X. K. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302779 · Cited by 42
“Ets transcription factors can be both positive and negative regulators of transcription, and interactions with other transcription factors can lead to increased DNA-binding ability and synergistic activation or repression (27, 31).”
BackgroundManavathi, B., Rayala, S. K., & Kumar, R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702309200 · Cited by 42
Identification of muscle-specific regulatory modules inCaenorhabditis elegans
Zhao, G., Schriefer, L. A., & Stormo, G. D. (2007) · Genome Research · doi:10.1101/gr.5989907 · Cited by 49
“Mounting evidence suggests that complex, cooperative protein–protein interactions between transcription factors are required to determine gene expression patterns (Arnone and Davidson 1997; Kamachi et al. 2000; Li et al. 2000; Remenyi et al. 2004).”
BackgroundETV7 limits antiviral gene expression and control of influenza viruses
Froggatt, H. M., Harding, A. T., Heaton, B. E., & Heaton, N. S. (2021) · Science Signaling · doi:10.1126/scisignal.abe1194 · Cited by 45
Sato, S., Richard, M. L., Brandon, D., Buie, J. N. J., Oates, J. C., Gilkeson, G. S., & Zhang, X. K. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38818 · Cited by 41
“Members of this large gene family affect gene transcription through both activation and suppression of target genes (25,26), many of which are critical for the control of cellular proliferation, differentiation, and apoptosis.”
BackgroundERF and ETV3L are retinoic acid-inducible repressors required for primary neurogenesis
Janesick, A., Abbey, R. J., Chung, C. M., Liu, S., Taketani, M., & Blumberg, B. (2013) · Development · doi:10.1242/dev.093716 · Cited by 45
“…function as transcriptional activators or repressors that interact with other factors to facilitate combinatorial, context-specific regulation of gene expression (reviewed by Hollenhorst et al., 2011; Li et al., 2000; Mavrothalassitis and Ghysdael, 2000; Oikawa and Yamada, 2003; Sharrocks, 2001).”
BackgroundRay, U., Chowdhury, S., Vasudevan, M., Bankar, K. G., Roychoudhury, S., & Roy, S. S. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12046 · Cited by 38
“Although studies have highlighted posttranscriptional regulation of ETS-1 activity (Ladykowska et al., 2002), as well as protein–protein interaction defining its target specificity (Li et al., 2000), relatively little is known about the transcriptional regulation ETS-1 activity in different cancers.”
BackgroundSchaefer, J. S., Sabherwal, Y., Shi, H. Y., Sriraman, V., Richards, J. S., Minella, A. C., Turner, D. P., Watson, D. K., & Zhang, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.073932 · Cited by 38
Self-citationCho, J., Akbarali, Y., Zerbini, L. F., Gu, X., Boltax, J., Wang, Y., Oettgen, P., Zhang, D., & Libermann, T. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309074200 · Cited by 43
Functional analysis of the EWS/ETS target gene uridine phosphorylase.
Deneen, B., Hamidi, H., & Denny, C. T. (2003) · PubMed · Cited by 37
Richard, M. L., Nowling, T. K., Brandon, D., Watson, D. K., & Zhang, X. K. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.07.013 · Cited by 36
Self-citationNovel Inhibitors of Matrix Metalloproteinase Gene Expression as Potential Therapies for Arthritis
Mix, K. S., Sporn, M. B., Brinckerhoff, C., Eyre, D., & Schurman, D. J. (2004) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000144483.62033.8b · Cited by 39
Genomic characterization of remission in juvenile idiopathic arthritis
Jiang, K., Frank, M. B., Chen, Y., Osban, J., & Jarvis, J. N. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4280 · Cited by 38
Travagli, J., Letourneur, M., Bertoglio, J., & Pierre, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403223200 · Cited by 46
Erm/Thyroid Transcription Factor 1 Interactions Modulate Surfactant Protein C Transcription
Lin, S., Perl, A. T., & Shannon, J. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602221200 · Cited by 35
Volvariella volvacea lectin activates mouse T lymphocytes by a calcium dependent pathway
Sze, S. C. W., Ho, J. C. K., & Liu, W. K. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20153 · Cited by 35
“Currently experiments are being conducted in our laboratories to elucidate the involvement of other transcription factors, including Ets and its family members [Li et al., 2000; Koskela and Lassila, 2002], in T cell activation by VVL.”
BackgroundThompson, H. G. R., Harris, J. W., Lin, L., & Brody, J. P. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.01.019 · Cited by 36
“We cotransfected PDEF, Ets-1, and PEA-3/E1A-F with various zibra promoter constructs either alone or in combination.”
BackgroundInfluentialRegulation of integrin α10 expression in chondrocytes by the transcription factors AP-2ε and Ets-1
Wenke, A., Rothhammer-Hampl, T., Moser, M., & Bosserhoff, A. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.04.123 · Cited by 44
Transcriptional Regulation of CD1D1 by Ets Family Transcription Factors
Geng, Y., Laslo, P., Barton, K., & Wang, C.-R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.1022 · Cited by 37
“Ets transcription factors usually work in concert with other transcription factors, maximizing specificity and tightly regulating gene expression (57).”
BackgroundExpression profile analysis of the inflammatory response regulated by hepatocyte nuclear factor 4α
Wang, Z., Bishop, E. P., & Burke, P. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-128 · Cited by 38
“Such interactions coordinate cellular processes in response to diverse signals including cytokines, growth factors, antigen and cellular stresses [41], here we believe that we have uncovered a novel interplay between the transcription factors HNF4a and ELK1 for controlling gene expression in the liver.”
BackgroundEts-1 binds cooperatively to the palindromic Ets-binding sites in the p53 promoter
Baillat, D., Laitem, C., Leprivier, G., Margerin, C., & Aumercier, M. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.11.035 · Cited by 39
Cabral, A., Fischer, D. F., Vermeij, W. P., & Backendorf, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300508200 · Cited by 38
Kaur, J., & Tikoo, K. (2015) · Oncogene · doi:10.1038/onc.2014.447 · Cited by 33
Metadata
- Authors
- Li, R., Pei, H., & Watson, D. K.
- Affiliations
- Medical University of South Carolina (US)
- Venue
- Oncogene
- Published
- 2000-12-18
- Volume
- 19
- Issue
- 55
- Pages
- 6514-6523
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1969499006
- Semantic Scholar
- 55c1025171d826abcc152117a531ab2603e58604
- Cited by
- 229
- References
- 131
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 4 · 2022: 6 · 2021: 7 · 2020: 7 · 2019: 2 · 2018: 4 · 2017: 4 · 2016: 15 · 2015: 8 · 2014: 11 · 2013: 9 · 2012: 5
- FWCI
- 1.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Cancer Society
- National Institutes of Health
- National Cancer Institute (P01-CA78582, P01CA078582)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Keywords
- ETS transcription factors, protein-protein interaction, ETS domain, transcriptional regulation, AP-1, NF-κB, Pax transcription factors, bHLH domain, bZIP domain, paired domain, subcellular localization, DNA binding, signal transduction
- MeSH terms
- Animals, Binding Sites, DNA, DNA-Binding Proteins, Gene Expression Regulation, Multigene Family, Humans, Mammals, Models, Genetic, Nuclear Proteins, Protein Binding, Proto-Oncogene Proteins, Transcription Factors, Transcription, Genetic, Trans-Activators, Retinoblastoma Protein, NF-kappa B, Consensus Sequence, Protein Structure, Tertiary, Transcription Factor AP-1, Dimerization, Amino Acid Motifs, Macromolecular Substances, Proto-Oncogene Proteins c-ets, Basic Helix-Loop-Helix Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.